Dr. Richard Chin, Chief Executive Officer, will present and be available for one-on-one meetings.
SAN FRANCISCO, Nov. 14, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, will participate in the Stifel Healthcare Conference on November 19 in New York City and Jefferies London Healthcare Conference on November 21. Dr. Richard Chin, Chief Executive Officer, will present and be available for one-on-one meetings. During this time, investors will have the opportunity to discuss recent developments, including the launch of KindredBio’s first product, study results from key therapeutic programs in development, and upcoming milestones. Conference Details: Stifel Healthcare Conference Date: Tuesday, November 19, 2019 Presentation time: 10:20-10:50a.m. ET in Kennedy Location: Lotte New York Palace Hotel Webcast URL: Click here Jefferies London Healthcare Conference Date: Thursday, November 21, 2019 Location: Waldorf Hilton, London An archived version of the above webcast will be available for 30 days on the KindredBio website. About Kindred Biosciences Important Safety Information Contact View original content to download multimedia:http://www.prnewswire.com/news-releases/kindred-biosciences-to-participate-in-stifel-healthcare-conference-and-jefferies-london-healthcare-conference-300958769.html SOURCE Kindred Biosciences, Inc. | ||
Company Codes: NASDAQ-SMALL:KIN |